Severe traumatic events such as burns, and cancer therapy, often involve a significant loss of tissue, requiring surgical reconstruction by means of autologous muscle flaps. The scant availability of quality vascularized flaps and donor site morbidity often limit their use. Engineered vascularized grafts provide an alternative for this need. This work describes a first-time analysis, of the degree of in vitro vascularization and tissue organization, required to enhance the pace and efficacy of vascularized muscle graft integration in vivo. While one-day in vitro was sufficient for graft integration, a three-week culturing period, yielding semiorganized vessel structures and muscle fibers, significantly improved grafting efficacy. Implanted vessel networks were gradually replaced by host vessels, coupled with enhanced perfusion and capillary density. Upregulation of key graft angiogenic factors suggest its active role in promoting the angiogenic response. Transition from satellite cells to mature fibers was indicated by increased gene expression, increased capillary to fiber ratio, and similar morphology to normal muscle. We suggest a "relay" approach in which extended in vitro incubation, enabling the formation of a more structured vascular bed, allows for graft-host angiogenic collaboration that promotes anastomosis and vascular integration. The enhanced angiogenic response supports enhanced muscle regeneration, maturation, and integration.
angiogenesis | tissue engineering | vascular biology | regenerative medicine F laps serve as important elements in reconstructive surgery, however, the availability of quality autologous muscle flaps, donor site morbidity, length of procedures, and cosmetic concerns present significant limiting factors (1) (2) (3) (4) (5) (6) . Tissue survival is dependent on oxygen supply, which is limited to a diffusion distance of up to 300 μm from a supplying blood vessel (7, 8) . Therefore, long-term survival and function is depending on rapid vascularization, which provides for the metabolic needs of the tissue. Suitable flaps lacking a sufficient blood supply may undergo necrosis (9) . Engineered vascularized muscle graft may offer a clinically relevant alternative to the autologous muscle flap. However, neither the in vitro and in vivo interactions between the vasculature network and muscle fibers, nor the influence of these interactions on graft survival and postimplantation viability, have been fully elucidated (10) . This work describes the dynamics of vascularized muscle graft integration in vivo. More specifically, we investigated the degrees of prevascularization and myogenesis required for improved implantation prospects. Extended incubation periods in vitro, yielded a semiorganized vascularized graft that actively contributed to angiogenesis and enhanced perfusion in vivo. In turn, accelerated host vasculature ingrowth and replacement of the preorganized vascular-like network, were observed. The improved angiogenic response influenced muscle fiber interactions with host blood vessels, along with their spatial organization and maturation. This improved integration had similar morphology to the normal muscle tissue, thus presenting new insights into the approaches of vascular and muscle integration.
Results
In Vitro Tissue Dynamics. Grafts were constructed using a triculture system of endothelial cells (ECs), myoblasts, and foreskin fibroblasts on biodegradable Surgisis scaffolds SIS is a resorbable, acellular bioscaffold, composed of extracellular matrix proteins derived from the jejunum of pigs, and has been shown to be completely replaced by the host within 90 d (11, 12) . SIS contains a variety of factors including VEGF and FGF2 that are known angiogenic factors (12, 13) , thus it has the potential to promote remodeling instead of a scar tissue (14) . The triculture tissue proliferated and differentiated on the scaffold in vitro (Fig. 1) . Within the first day of seeding, ECs had already spread from the center, where they had been seeded, and covered most of the scaffold area ( Fig. 1 A and B) . Following one week of incubation, ECs organized in two, spatially-distinct populations, where the lower layer included anastomosed ECs arranged in network-like structures, while the upper layer population was composed of single ECs. As the latter population gradually disappeared over the ensuing two and three weeks of incubations, most of the anastomosed structures expanded in diameter (Fig. 1C) . At early stages of culturing, a number of anastomosed structures located along the tissue perimeter were open, yet with time, those situated at the tissue center opened as well. By three weeks postseeding, most structures were open and demonstrated vessel-like, branched networks (Fig. 1A) . A dense and uniform myoblast population was observed, where fusion to multinucleated myofibers was already noted within one week of seeding. After three weeks in culture, straight, long fibers were observed extending across the scaffold (Fig. 1B) . Grafts did not change in shape or size, as can be seen in Fig. 1A , which shows the entire surface of the scaffolds, up to the perimeters. We have shown before that myobalsts grown on poly-lactic co glycolic acid (PLGA) scaffold can exert forces that change its shape (15) . However, this effect was not observed in the three-culture system, on SIS scaffolds, where most of the cells were ECs. One can affect cells and tissue organization using mechanical loading, oxygen gradient, or electrical stimulus. For example, we have shown before that different scaffold stiffness influence myoblasts viability, organization, and myotube formation (15) . We did not use any of these methods, therefore the observed pattern of aligned fibers is probably the intrinsic organizing pattern of the myoblasts. ECs and myoblasts proliferated on the scaffold and began their respective differentiation processes but did not integrate to form classic, parallel and aligned fibers and vessels as in the mature muscle. In Vivo Graft Integration. In order to assess the effects of in vitro incubation periods on tissue integration prospects in vivo, a full thickness segment of the abdominal wall of nude mice, was replaced with muscle grafts of varying degrees of maturity (3, 16) . All grafts were retrieved and imaged two weeks postimplantation. This model enabled us to capture the dynamics of angiogenesis and muscle formation during integration due to host-graft interactions. Intravital microscopy and perfusion of FITC-dextran demonstrated that grafts were viable, and connected to the host via large vessels branching from the epigastric blood vessels ( Fig. 2A, Fig. S1A ). These large vessels branched to microvessels upon reaching the grafts. Grafts were also connected to the surrounding tissue via microvessels that bent upon reaching the grafts ( Fig. 2 A and B) . In vivo morphology of graft microvessels was highly dependent on the length of the graft's incubation period in vitro (Fig. 2B) . One-day in vitro grafts exhibit loose, scattered vessel networks, while one-week in vitro grafts networks were denser. Two-week in vitro grafts demonstrated a number of aligned and paralleled vessels as can be seen in the middle of the grafts, while in three-week in vitro grafts all vessels were long, paralleled, and stretched from one side of the graft to the other. Muscle formation was evident in all grafts (Fig. 2C ). Fibers were more ordered and closely arranged upon extended in vitro culturing times. One-day in vitro grafts present a loose organization while all the rest present dense groups of myotubes. The most mature morphology, including parallel muscle fibers and paralleled blood vessels that were also aligned together, as observed in a mature muscle tissue, was observed in three-week in vitro grafts, two weeks postimplantation ( Fig. 2 C-E).
In order to determine the functionality of our preformed vessel network, we used muscle grafts engineered with Human Umbilical Vein Endothelial Cells (HUVEC)-GFP. At 14 d postimplantation, we perfused rhodamine-dextran and monitored graft-host integration. Surprisingly, one day of incubation in vitro was sufficient to create viable, functional HUVEC-GFP vessels that exhibited a flow of rhodamin-dextran through them ( Fig. 3 A and B) , despite the fact that the EC population was undifferentiated in vitro (Fig. 1A) . With extended incubation times, fewer GFP vessels were detected, from 121.26 AE 36.85 per mm 2 in one-day grafts to 5.43 AE 2.02 per mm 2 in three-week grafts ( Fig. 3 A and C). We analyzed FITC-dextran accumulation within implanted muscular grafts as a measure of perfusion of functional vessels. Engineered vascularized grafts showed better perfusion than an empty scaffold or grafts engineered only with myoblasts ( Fig. 4A ). Among the vascular grafts, longer culture periods resulted in higher FITC signal intensity (Fig. 4A ), meaning better perfusion of blood vessels. The amount of vessels and their diameter influence perfusion, as larger vessels can carry more FITC-dextran. Blood vessel density was increased from 161.37 AE 71.69 per mm 2 in one-day in vitro grafts to 556.2 AE 188.11 mm 2 in three-week in vitro grafts (Fig. 4B) . It was coupled with an increase in smooth muscle actin (SMA) density, from 25.75 AE 13 per mm 2 in one-day in vitro grafts to 100.7 AE 41.4 per mm 2 in three-week in vitro grafts (Fig. 4C, Fig. S1B ). We also analyzed blood vessels diameter and found an increase in mean diameter from 17 AE 9 μm in one-day in vitro grafts to 31 AE 10 μm in two-week in vitro incubated grafts. However, vessel diameters decreased to 27 AE 8.7 μm in threeweek in vitro grafts (Fig. 4D) . These results suggest that the observed increased perfusion in three-week in vitro grafts was due to increased number of small blood vessels that compensated for the larger vessels observed in two-week in vitro grafts. Analysis of vessel diameter distribution revealed that microvessels under 10 μm in diameter were present at one-day in vitro grafts but not in one-and two-week in vitro grafts. However, these vessels were detected again in three-week in vitro grafts (Fig. 4E) . We examined adjacent normal rectus abdominis muscle and found that most of the vessels were less than 10 μm in diameter (Fig. 4E) . These results show that the vessel network, 14 d postimplantation, in threeweek in vitro grafts, was the closest to the one observed in a normal mature muscle. Capillary per fiber ratio (C/F) was increased with in vitro culturing times, where the C/F ratio of three-week in vitro grafts (2.6 AE 0.2) was relatively similar to that of the normal adjacent rectus abdominis muscle (3.1 AE 0.3) (Fig. 4F) . These results strengthen the previous observation that improved perfusion in three-week in vitro grafts was the result of higher number of microvessels. Furthermore, we observed continues expansion in muscle fiber diameter although fibers were still relatively small in comparison to normal muscle (Fig. 4G) .
In Vivo Gene Expression. Gene expression patterns in grafts were studied in an effort to define the events controlling angiogenesis, muscle fibers development, and ECM arrangement. A sharp decrease in EC-expressed human Platelets Endothelial cell adhesion molecule (PECAM-1), progenitor EC marker (CD34), Von Willebrand factor (vWF), and VEGFR-2 (KDR) was seen (Fig. S2A) , correlating with the observed progressive decrease of HUVEC- GFP in vivo as incubation times extended (Fig. 3A) . In contrast, the human morphogenes, capillary morphogenesis genes (CMG-1, CMG-2, and CD39), angiogenic factors (VEGF-A, VEGF-B, and FGF2) and the hypoxia marker HIF1α, all critical factors in angiogenesis, vessel survival, and stabilization (17) (18) (19) (20) (21) (22) (23) (24) (25) , were still highly expressed in three-week in vitro grafts (Fig. S2A) . We have previously reported (16) that in the presence of ECs, foreskin fibroblasts differentiate to smooth muscle cells, colocalize with ECs, and secrete VEGF in vitro. To address this issue we labeled HFF cells with DiI (1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate) prior to implantation and visualize them at the end point. Here we show that HFF cells survived and differentiated to smooth muscles exhibiting close interaction with blood vessels (Fig. S1C ). This observation means that they were the source of the additional human angiogenic factors expression. Increased expression of the mouse ECs genes PECAM-1, Flk1, and thrombomodulin (THBD), supported formation and stabilization of host blood vessels (21) (Fig. S2B) , while human ECs decreased in number (Fig. S2A) . We observed a phenomena where low expression levels of mouse HIF1α,VEGF-A VEGF-B, FGF-2, Angoipoietin-2, CMG-1, and CMG-2 genes were observed while their human counterparts were highly expressed. (Fig. S2B ). On the other hand it was also interesting to note that PDGF-B, which is important for vessel stabilization, was highly expressed by the host, and by the graft as well. Mouse muscle markers Pax7, c-Met, N-cam, M-cadherin, Myf5, and myogenin were upregulated (Fig. S2C) , suggesting substantial muscle regeneration involving satellite cells activation, proliferation, differentiation, fusion to myofibers, and maturation (26) (27) (28) (29) (30) . This expression profile was accompanied by increased expression of ECM components (Fig. S2D) , including collagen 1, collagen 3, collagen 4, collagen 6, laminin chains α5, β1, and fibronectin. Expression of MuSK, DOK7, and laminin chains α4, α2, β2, γ1, all associated with neuro-muscular junctions (NMJ) (31-35), were not upregulated in the grafts, relatively to one-day in vitro graft. The neural marker β3-Tubulin, demonstrates that the NMJ in one-day in vitro graft was only partially developed ( Fig. S1F) , suggesting that it is not yet fully formed and organized.
In Vivo Muscle Functionality. Muscle function (contraction) was assessed by measuring the passive and active forces at 6-8 different muscle lengths for each construct, in order to obtain the forcelength curves (as described in the Materials and Methods). The empty group showed negligible or no active stress development ( Fig. 5A ) with mean F a ¼ 6.3 AE 7.6%, (F a represents the percent of active stress out of the total at L max ). Both one-day and threeweek in vitro grafts showed significantly increased active stress with mean F a ¼ 34.5 AE 20.4% (Fig. 5B) . Force-length relationship curves also stress grafts active response (Fig. 5C ). Most triculture grafts showed an increase in force for increased muscle length (up to a certain length-L max ), as expected from normal muscle tissue. Movies of graft contractions in response to stimulation are shown in Movie S1, Movie S2, and Movie S3.
Discussion
One of the major obstacles for the generation of clinically applicable tissue is to keep it viable in vivo. Successful implantation is dependent on revascularization and anastomosis of the implant with the host vasculature, otherwise ischemia and necrosis set in. This study reveals the in vivo dynamics of graft vascular integration and angiogenesis. The degree of the vascular bed organization in vitro directly influences host penetration to the graft, and the remodeling of the vascular network. Incubation of one day, where ECs were not organized yet (Fig. 1A) , was sufficient for differentiation and anastomosis with the host (Fig. 3 A and B) . This short incubation was also sufficient to yield blood perfusion that was better than grafts without ECs (Fig. 4A) . However, in vivo perfusion and vessel density improved dramatically as incubation time lengthened to three weeks and ECs were allowed to be better organized (Fig. 1A, Fig. 4 A and B ). This observation was followed by increased coverage with smooth muscle cells leading to stabilization and maturation of vessels (Fig 4C,  Fig S1B) . The improved preorganization resulted in faster replacement of graft vessels by host vessels. Fewer GFP vessels per mm 2 were detected until barely seen on three-week grafts, while total number of blood vessel per mm 2 increased (Fig. 3 A and C). This result was supported by ECs gene expression patterns that showed a reduction in human endothelial markers ( Fig. 4 A and B) . The newly formed vessels exhibit an increase in vessel diameter, which is a known result of ischemia (36). This increase was followed by a decrease in vessel diameter and aligned morphology. These observations outline a transformation from massive blood supply to one engaged in detailed tissue needs, providing for the progress of graft muscle maturation ( Fig. 2 C and D, Fig. 4E ). We suggest a host-graft collaboration where the angiogenic process was actively supported by key graft angiogenic factors, expressed by HFF derived smooth muscle cells. HIF1α, FGF2, and VEGF-A graft expression, along with expression of vessel stabilization factor PDGF-B by both host and graft, demonstrate that both host and graft promote implant integration (Fig. S2B) . A recent report by Frontini, et al. showed that exogenous addition of FGF9, a factor that is upregulated by the mural cells and increase their recruitment, enhanced the angiogenic response in ischemic mouse hind limb (37) . Our results enhance this finding, showing the active contribution of graft mural cells together with host stabilization of newly formed blood vessels. It has been shown that VEGF and PDGF mRNA increased expression, correlate with increased protein expression and increased vessel density, in animal and human angiogenic scenarios, such as human breast cancer, non-small-cell lung cancer, melanoma, and atherosclerotic lesions (38) (39) (40) (41) (42) . We show that as well; a correlation between increased mRNA expression, improved vessel density, and tissue organization. Hif1α is a factor that is constitutively expressed in the cell, and degraded in normoxia. In hypoxia, Hif1α is stabilized and exerts its effect. Nevertheless, a number of groups reported the correlation between increased mRNA and increased protein expression of Hif1α that also correlated to increased vascular density. Hif1α increased levels also correlated to increased VEGF levels that, as mentioned earlier, correlate to increased vascular density (43) (44) (45) (46) (47) (48) (49) (50) (51) . We also show this pattern in our gene expression research which correlates to the increased vascular density, as observed in the grafts. Thus, we have demonstrated that an implant can actively contribute and collaborate with the host, to promote its own integration. Shen, et al. and Suda, et al. showed that in the bone marrow and the hippocampus, progenitor cells respond to angiogenic factors, produced by the vascular bed. These factors were shown to be essential for proliferation, differentiation, and neurogenesis of the progenitor cells (52, 53) . This study shows that the preimplanted vascular bed is essential for graft integration and organogenesis in vivo. In a regenerated muscle, once the myotubes are formed, they go through a maturation process during which they become innervated and vascularized, resulting in myofibers (10) . Myofibers are then packed together by connective tissues to provide strength to the muscle. The parallel alignment of the myoblasts during fusion is the key to what gives the myofibers their ability to produce the force necessary for movement and strength (10, 54) . We have brought together the vascular bed and myoblasts to improve muscle regeneration. Our grafts exhibited an increase in fiber diameter and capillary per fiber ratio in vivo (Fig. 4 E and F) as incubation time is prolonged. Further tissue maturation, similar to the normal rectus abdominis muscle, was evident by coalignment of blood vessels with muscle fibers in three-week in vitro graft (Fig. 2 C-E) . This coalignment was not demonstrated in grafts engineered with only myoblasts, (Fig. S1D) . Another control of empty SIS scaffold in vivo, showed scattered blood vessels and single, unfused, myoblasts population that resembled the single cell population observed in one-day in vitro grafts (Fig. S1E, Fig. 1B ). All stages in the muscle regeneration process, from satellite cells to mature muscle, were demonstrated by real-time PCR, showing increased expression of relevant markers (Fig. S2C) . This maturation was accompanied by an increase in the expression of ECM components (Fig. S2D ). These components have structural roles in interstitial connective tissue and basement membrane development during angiogenesis and myogenesis, and are important to vessel function and stabilization, as well as muscle structure and force transduction (26, 32, 33, (54) (55) (56) .
The functional study showed that our triculture graft contracts in vivo in response to stimulation, while the empty scaffold did not exhibit any activity. Although we could not show significant differences in activity between one-day and three-week in vitro grafts it was clear that three-week in vitro grafts were highly integrated with the host muscles, which made it very difficult to dissect the grafts based on boundary visibility (Fig. S3 B-D) . The active force was about 35% of an intact muscle. This result was expected because our additional data support the fact that the grafts are not fully matured in terms of muscle fibers maturation (Fig. 4 F-G, Fig. S2D, Fig. S1F ) and NMJ formation after only 14 d in vivo. Nevertheless, contraction after such a short integration period is very impressive.
The results of this study substantiate the need for vascularization and emphasize its importance for implant integration. We suggest a unique "relay" approach to engineered vascularized graft integration in vivo. The relay is the competition between the various tissue organizations states examined in vitro, to result in a more advanced maturation and integration in vivo. The more advanced organization (three-week in vitro grafts) resulted in faster anastomosis, maturation, and replacement by the host. In tissue engineering and cell therapy where endothelial cells are being used, investigators seeking to find their implanted cells or vessels in vivo, so they can show a prolonged and sustained effect over time (57) . We suggest the opposite. We show that increased incubation allows for a more advanced organization that results in better perfusion increased vessel density and maturity, but gradual decrease in implanted HUVEC-GFP. Meaning once the implanted vessels anastomosed and perfused, the host is able to quickly remodel the blood vessel network to its needs. Another result is a more advanced fiber maturation and morphology where vessels and fibers are parallel and aligned, as in a mature muscle. We show the effect of ECs addition to the graft, and the resulted formation of tissue structures-the vascular tree, fibers organization, and their interaction. In addition, we suggest a collaboration in the angiogenic process, where some angiogenic factors were expressed by the graft (VEGF-A, VEGF-B, FGF2,, and HIF1α) and not by the host, while one factor (PDGF-B) was highly expressed by both. This suggested collaboration supported the observed improved integration, which results in partial functionality 14 d postimplantation, and morphology and organization that resemble the normal mature muscle organization.
Materials and Methods
Cell Culture. C 2 C 12 mouse myoblast cells [American Type Culture Collection (ATCC)] were cultured in DMEM supplemented with 20% FBS, and 2.5% Hepes buffer. Human Umbilical Vein Endothelial Cells (HUVEC, Clonetics) and HUVEC-GFP (Angio-Proteomie) were cultured in endothelial cell medium (EGM-2, EGM-MV, and their respective bullet kits, Cambrex Bio Science Walkersville, Inc.). Human foreskin fibroblasts were cultured in DMEM supplemented with 10% FBS and 1% nonessential amino acids.
Graft Preparation. Four-ply Surgisis (Cook Biotech Inc.) were rehydrated according to the manufacturer's instructions. For seeding, the desired number of cells were pooled and resuspended in 3□l culture medium. The suspension was placed on the scaffold and was allowed to be absorbed (1.5 h, 37°C, 5% CO 2 ), after which 3 mL of 1∶1 HUVEC-GFP:C2C12 media were added. Medium was replaced every other day. We have previously refined these conditions of media and cell numbers (16) .
Fibroblast Labeling. Cells were labeled [45 min, room temperature (RT)], directly on culture plates, with 3 μL∕mL Vybrant DiI (In Vitrogen) diluted in medium, and then washed three times with PBS.
Implantation of Muscle Grafts. All surgical procedures were conducted according to protocols approved by the Institutional Animal Care and Use Committee. Male, 8 w old, nude mice (Harlan Laboratories) were divided randomly to four groups, five mice per group. Mice were anesthetized using a ketamine: xylazine cocktail at a dose of 35 μL∕20 g delivered with a 25-gauge needle. A small incision was made allowing access to the linea-alba and surrounding tissue, where a 3 × 2 mm full thickness defect segment was removed. Muscle grafts were sutured in place using four 8-0 silk sutures. All mice were monitored closely for 1-2 h to ensure full recovery from the anesthesia. Mice were anesthetized two weeks later and 10 mg∕mL FITC-dextran or rhodaminedextran (Sigma) were perfused through the tail vein. Grafts were either imaged or immediately placed into RNAlater buffer (Qiagen) until RNA extraction was performed as described below.
Tissue Processing and Immunohistochemical Staining. Whole mount: Grafts were fixed in 4% paraformaldehyde (30 min, RT) followed by extensive washing in PBS and overnight blocking (10% FBS, 0.1 g glycine, 0.1% Triton X-100, in PBS). Skeletal muscles were labeled using a goat polyclonal desmin antibody (Santa Cruz Biotechnology), smooth muscles were labeled using mouse SMA (DAKO), mouse blood vessels were labeled using FITC-ILB4 (Vector Labs), and NMJ was labeled using mouse anti βIII-tubulin (Promega). All antibodies were diluted in fresh blocking serum and incubated with samples overnight at 4°C. Following extensive washings, donkey anti-goat, or goat anti-mouse Cy3 antibodies (Jackson ImmunoResearch Laboratories Inc.) and DAPI (Sigma) were diluted in PBS and incubated with the grafts (3 h, RT). Serial sections: Grafts were fixed for 30 min in 10% neutral buffered formalin, routinely processed, and embedded in paraffin. Serial sections (5 μm) were placed on silanized slides for immunohistochemistry as described above.
Imaging. Intravital images were captured using an Olympus fluorescent stereo microscope (SZX12). In vitro and ex-vivo images were taken with a Zeiss LSM 510 Meta Confocal microscope and Leica TCS-LSI confocal microscope. Slides were imaged using a Zeiss fluorescent microscope (Axiovert-200M).
Image Analysis. FITC intensity was measured using NIH ImageJ software, as were vessels and muscle fiber numbers and diameters. For HUVEC-GFP and vessel area calculations, images were segmented followed by quantification of signal area.
Statistical Analysis. Results were analyzed using one-tail ANOVA followed by Tukey's test using JMP 8.0 (SAS); α < 0.05 was considered statistically significant.
RT-PCR Analysis. Total RNA was isolated using RNEasy Midi Kit (Qiagen) according to the manufacturer's muscle tissue isolation protocol. RT-PCR was performed using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). TaqMan assays were performed using custom gene expression plates and probes (Applied Biosystems), as detailed in 19 .0 HCO3−, and 10.0 glucose; pH was set at 7.40 by adjusting the flow of the gas mixture (95% O2, 5% CO2). Calcium concentration was 1.5 mM. The constructs were dissected based on the borders of the scaffold with small ends of surrounding tissue on each side for force transducer and motor arm insertion (Fig. S3A) . The dimensions of all the constructs were fairly similar of about 4 × 3 × 1 mm. The experimental bath was placed on a stage of an inverted microscope (TE300, Nikon). The bath was perfused at a constant rate, and the temperature was kept at 25°C. The constructs were stimulated at 0.2 Hz. The stimulation amplitude was 1.5 times the stimulus threshold for maximal force production. Force was measured by a silicone strain gauge (SensorOne AE801). Muscle length was controlled by a fast servomotor (Aurora Scientific, model 308B) and monitored by a precise capacitance sensor attached to the motor axis. Tetanic stimulation (50 Hz) was performed following every regular twitch. Passive stress was calculated from baseline force at each length and active stress was calculated from the developed steady force at tetanus. Muscle length was measured from the calibrated signal of servomotor location. Muscle length and force were sampled at 5,000 Hz. Each measurement was repeated five times, and the results were averaged in order to reduce the random noise.
